Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

Share Price is delayed by 15 minutes
Get Live Data
240.50    5.00 (2.12%)
Bid:
239.00
Ask:
240.00
Spread: 1.00 (0.418%)
Market Cap: £1.43b
MAB Live PriceLast checked at - London Stock Exchange

Intraday Mitchells & Butlers Share Chart

Form 8.5 Mitchells & Butlers Plc

27 Sep 2011 07:50

RNS Number : 9836O
Nomura International PLC (EPT)
27 September 2011
 



FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nomura International Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mitchells & Butlers Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Mitchells & Butlers Plc

(d) Date position held/dealing undertaken:

26 September 2011

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

8 13/24p ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

195,724

0.048%

121,851

0.030%

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

195,724

0.048%

121,851

0.030%

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary Shares

Purchase

880

2.4880

Ordinary Shares

Purchase

204

2.4890

Ordinary Shares

Purchase

470

2.4940

Ordinary Shares

Purchase

1,218

2.4950

Ordinary Shares

Purchase

383

2.4970

Ordinary Shares

Purchase

2,397

2.5010

Ordinary Shares

Purchase

294

2.5020

Ordinary Shares

Purchase

1,398

2.5030

Ordinary Shares

Purchase

588

2.5050

Ordinary Shares

Purchase

1,777

2.5060

Ordinary Shares

Purchase

4,821

2.5070

Ordinary Shares

Purchase

3,035

2.5080

Ordinary Shares

Purchase

11,611

2.5100

Ordinary Shares

Purchase

3,441

2.5103

Ordinary Shares

Purchase

558

2.5110

Ordinary Shares

Purchase

100

2.5130

Ordinary Shares

Purchase

3,064

2.5140

Ordinary Shares

Purchase

2,305

2.5150

Ordinary Shares

Purchase

2,190

2.5160

Ordinary Shares

Purchase

2,777

2.5180

Ordinary Shares

Purchase

2,830

2.5190

Ordinary Shares

Purchase

2,171

2.5210

Ordinary Shares

Purchase

3,511

2.5220

Ordinary Shares

Purchase

3,380

2.5230

Ordinary Shares

Purchase

8,824

2.5240

Ordinary Shares

Purchase

65,441

2.5250

Ordinary Shares

Purchase

51,552

2.5256

Ordinary Shares

Purchase

2,979

2.5270

Ordinary Shares

Purchase

1

2.5290

Ordinary Shares

Purchase

1,744

2.5300

Ordinary Shares

Purchase

443

2.5360

Ordinary Shares

Purchase

463

2.5400

Ordinary Shares

Purchase

1,803

2.5410

Ordinary Shares

Purchase

3,663

2.5430

Ordinary Shares

Purchase

1,539

2.5450

Ordinary Shares

Purchase

1,021

2.5490

Ordinary Shares

Purchase

1,253

2.5510

Ordinary Shares

Purchase

440

2.5520

Ordinary Shares

Purchase

751

2.5530

Ordinary Shares

Purchase

1,044

2.5550

Ordinary Shares

Purchase

2,354

2.5560

Ordinary Shares

Purchase

5,656

2.5590

Ordinary Shares

Purchase

6,047

2.5600

Ordinary Shares

Purchase

5,906

2.5620

Ordinary Shares

Purchase

5,863

2.5630

Ordinary Shares

Purchase

3,424

2.5730

Ordinary Shares

Purchase

379

2.5750

Ordinary Shares

Sale

1,621

2.4890

Ordinary Shares

Sale

2,448

2.4900

Ordinary Shares

Sale

3,200

2.4930

Ordinary Shares

Sale

2,641

2.4940

Ordinary Shares

Sale

147

2.4960

Ordinary Shares

Sale

2,499

2.4980

Ordinary Shares

Sale

824

2.4990

Ordinary Shares

Sale

1,224

2.5000

Ordinary Shares

Sale

1,614

2.5020

Ordinary Shares

Sale

3,255

2.5030

Ordinary Shares

Sale

4,801

2.5040

Ordinary Shares

Sale

3,361

2.5060

Ordinary Shares

Sale

2,776

2.5070

Ordinary Shares

Sale

5,931

2.5080

Ordinary Shares

Sale

2,860

2.5090

Ordinary Shares

Sale

7,395

2.5100

Ordinary Shares

Sale

673

2.5110

Ordinary Shares

Sale

4,429

2.5120

Ordinary Shares

Sale

1,686

2.5130

Ordinary Shares

Sale

660

2.5140

Ordinary Shares

Sale

2,381

2.5150

Ordinary Shares

Sale

8,556

2.5160

Ordinary Shares

Sale

2,267

2.5170

Ordinary Shares

Sale

3,697

2.5180

Ordinary Shares

Sale

2,208

2.5200

Ordinary Shares

Sale

1,928

2.5210

Ordinary Shares

Sale

731

2.5230

Ordinary Shares

Sale

550

2.5240

Ordinary Shares

Sale

1,000

2.5250

Ordinary Shares

Sale

4,113

2.5260

Ordinary Shares

Sale

3,199

2.5280

Ordinary Shares

Sale

630

2.5290

Ordinary Shares

Sale

7,738

2.5300

Ordinary Shares

Sale

1,814

2.5310

Ordinary Shares

Sale

91,606

2.5319

Ordinary Shares

Sale

2,511

2.5360

Ordinary Shares

Sale

1,353

2.5380

Ordinary Shares

Sale

4,481

2.5390

Ordinary Shares

Sale

1,944

2.5400

Ordinary Shares

Sale

2,545

2.5410

Ordinary Shares

Sale

733

2.5420

Ordinary Shares

Sale

1,771

2.5430

Ordinary Shares

Sale

2,223

2.5440

Ordinary Shares

Sale

1,041

2.5480

Ordinary Shares

Sale

1,383

2.5510

Ordinary Shares

Sale

31

2.5520

Ordinary Shares

Sale

1,242

2.5530

Ordinary Shares

Sale

3,921

2.5540

Ordinary Shares

Sale

7,198

2.5560

Ordinary Shares

Sale

600

2.5570

Ordinary Shares

Sale

999

2.5580

Ordinary Shares

Sale

3,299

2.5590

Ordinary Shares

Sale

4,007

2.5620

Ordinary Shares

Sale

311

2.5700

Ordinary Shares

Sale

1,272

2.5720

Ordinary Shares

Sale

1,541

2.5730

Ordinary Shares

Sale

1,124

2.5740

Ordinary Shares

Sale

1,883

2.5780

Ordinary Shares

Sale

500

2.5810

 

TOTAL BUY - 227,993

TOTAL SELL - 234,376

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

27 September 2011

Contact name:

Kyere Tabiri

Telephone number:

020 7102 1267

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEODKODQABKKFCB
Date   Source Headline
29th May 202611:30 amRNSTotal Voting Rights
26th May 202612:00 pmRNSDirector/PDMR Shareholding
26th May 202611:30 amRNSDirector/PDMR Shareholding
21st May 20267:00 amRNSHALF YEAR RESULTS
14th May 20262:30 pmRNSNotice of Half Year Results
13th May 20263:30 pmRNSAdmission to Trading
30th Apr 20262:00 pmRNSTotal Voting Rights
27th Apr 20262:00 pmRNSDirector/PDMR Shareholding
24th Apr 20267:00 amRNSDirectorate change
31st Mar 20263:00 pmRNSTotal Voting Rights
30th Mar 20261:30 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:19 amRNSDirector/PDMR Shareholding
27th Feb 202611:50 amRNSTotal Voting Rights
13th Feb 20269:28 amRNSDirector/PDMR Shareholding
11th Feb 202611:00 amRNSDirectorate change
2nd Feb 20263:00 pmRNSDirector/PDMR Shareholding
30th Jan 20261:12 pmRNSTotal Voting Rights
29th Jan 20264:00 pmRNSResult of AGM
15th Jan 20267:00 amRNSFirst Quarter Trading Update
12th Jan 20261:30 pmRNSNotice of First Quarter Trading Update
5th Jan 20263:21 pmRNSDirector/PDMR Shareholding
2nd Jan 20269:27 amRNSTotal Voting Rights
18th Dec 202512:00 pmRNSAnnual Report 2025
18th Dec 202512:00 pmRNSAnnual Report 2025
15th Dec 202511:04 amRNSDirector/PDMR Shareholding
12th Dec 20251:49 pmRNSDirector/PDMR Shareholding
8th Dec 20252:00 pmRNSDirector/PDMR Shareholding
5th Dec 202512:16 pmRNSDirector/PDMR Shareholding
5th Dec 202512:15 pmRNSDirector/PDMR Shareholding
28th Nov 20252:40 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSFull Year Results
24th Nov 202512:30 pmRNSNotice of Final Results
10th Nov 20252:00 pmRNSDirector/PDMR Shareholding
31st Oct 202510:31 amRNSTotal Voting Rights
23rd Oct 20257:00 amRNSDirectorate Change
13th Oct 20252:27 pmRNSDirector/PDMR Shareholding
1st Oct 202510:07 amRNSBlock listing Interim Review
30th Sep 20251:58 pmRNSTotal Voting Rights
25th Sep 20257:00 amRNSPre-Close Trading Update
23rd Sep 202512:29 pmRNSNotice of Pre-Close Trading Statement
15th Sep 202512:00 pmRNSDirector/PDMR Shareholding
29th Aug 20252:00 pmRNSTotal Voting Rights
18th Aug 20251:59 pmRNSDirector/PDMR Shareholding
31st Jul 202511:18 amRNSTotal Voting Rights
25th Jul 20257:00 amRNSThird Quarter Trading Update
22nd Jul 202510:15 amRNSNotice of Third Quarter Trading Update
21st Jul 20252:30 pmRNSDirector/PDMR Shareholding
15th Jul 202512:38 pmRNSListing Application
30th Jun 20253:00 pmRNSTotal Voting Rights
27th Jun 202512:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.